CEO and Co-founder Aitia
Cambridge, MA
Joined May 2011
- Tweets51
- Following40
- Followers164
- Likes17
Colin Hill retweeted
Honoring @RobertMMetcalfe, the father of the Ethernet, with a special reception. Distinguished leaders from Boston's innovation community celebrated Bob' transformative contributions to communication and connectivity. Congrats on the 2022 ACM #TuringAward!
Colin Hill retweeted
We are live from the @RouxInstitute with @brucechurch presenting our session titled "Causal AI for Learning #DigitalTwins from Human Multi-Omic Data for #DrugDiscovery and Clinical Development: A Cardiovascular Disease Case Study"
ALT Causal AI for Learning Digital Twins from Human Multi-Omic Data for Drug Discovery and Clinical Development
I’m so happy and proud of friend, advisor, and mentor Bob Metcalfe for this long overdue recognition! Congrats Bob on the 2023 Turing Award!
Last year, we had the privilege of hosting Bob Metcalfe for a private fireside chat with our CEO @ColinHill1, and we couldn't be more proud to see him receive this year's #TuringAward for his incredible contributions to Ethernet. Congratulations, Bob!
Colin Hill retweeted
FOR MEDIA: #HealthcareInnovation requires investment in next gen science & technology. So, it’s great to announce an exciting #multiomics, #AI, #DrugDiscovery, #CausalAI collaboration with @Aitiabio
I am delighted to share that @Aitiabio and @ucb_news have announced a strategic #drugdiscovery collaboration focused on the discovery and validation of novel drug targets and drug candidates for #Huntingtondisease
More about this announcement: aitiabio.com/aitia-and-ucb-a…
Colin Hill retweeted
Leaders in fields from chemistry to cancer research are among the Cambridge academics recognized at the #PlatinumJubilee. Congratulations to @adrian_weller, GNS board member awarded a special honor for his outstanding services to digital innovation. cam.ac.uk/stories/Birthday-H…
Exciting news! We are extremely happy to announce today our new partnership with @QIAGENBiox and their adoption of @gnshealthcare's Gemini – The in silico Patient™ across multiple cancers. bit.ly/38VYr0L
Excited to be moderating a panel tomorrow at the Longwood Healthcare Leaders Fall conference on Expediting the Path to Patient Care. I'll be joined by leaders from Bristol Myers Squibb, Illumina, BlackThorn Therapeutics, and Novartis.
Join me for the the #AI Applications for Drug Discovery and Development conference next week.
Excited to participate in this year's #STATHealthTech conference on 9/9-10. Other conference speakers include, Hal Barron of GSK and Levi Garraway of Roche. More details on the summit available here: hubs.ly/H0v4dz50
I will be speaking at @MassBio's virtual #StateOfPossible Conference on 8/26-8/27! Join me as we debate the most pressing challenges facing the #LifeSciences to ensure we can continue its incredible success & improve #patient lives. To learn more, visit: hubs.ly/H0t-8LQ0
Looking forward to joining the other panelists at the conference and discuss how @gnshealthcare is impacting #PrecisionMedicine .
Speaker Announcement!
Colin Hill Chairman & CEO, GNS Healthcare
Learn more about our #STATHealthTEch Summit here: buff.ly/2Qa2b4u
@ColinHill1 #HealthTech
"AI vendors are believed to provide tangible impact on the improvement of the clinical study process." @BiopharmaTrend
GNS Healthcare was named a notable #AI company with capabilities to optimize the clinical development process. Read more here:
hubs.ly/H0tLLR_0
Really enjoyed listening in on our webinar last week where the team dove into our work with CHDI on how we applied our #AI platform to discover biomarkers and subpopulations of disease progression in Huntington's. If you missed it, access it here: hubs.ly/H0tlZtK0
The presentation of our work is not only a validation of how #AI can extract critical insights from real-world data, but also a milestone in our mission to make precision #oncology a reality. hubs.ly/H0sMYPD0
Myeloma Research News covers the recent announcement of Gemini, the in silico patient. Read the piece here: hubs.ly/H0sKG4Z0
Looking forward to hearing from our team and partners at CHDI Foundation present on how we leveraged #AI to discover progression biomarkers and subpopulations in Huntington's Disease during our upcoming webinar. hubs.ly/H0snYPR0
Pleasure discussing Gemini, the in silico patient, and the impact of #AI in #pharma with Jacqueline Lisk for the @BostonGlobe.
hubs.ly/H0sp3Ds0
Precision #Oncology News, from @GenomeWeb covers Gemini, the in silico patient, and discusses our approach to reverse engineering and unraveling how multiple myeloma works.
Read more here: hubs.ly/H0s9rWM0
Today we announce the release of Gemini, the in silico patient for multiple myeloma. We are breaking the bottleneck of understanding which drugs work for what patients and transforming how we identify drivers of patient response to therapeutics. Read more: hubs.ly/H0rTTnB0